These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 16191171

  • 1. Parathyroid hormone assay drift: an unappreciated problem in dialysis patient management.
    Cantor T.
    Semin Dial; 2005; 18(5):359-64. PubMed ID: 16191171
    [Abstract] [Full Text] [Related]

  • 2. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 3. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.
    Cantor T, Yang Z, Caraiani N, Ilamathi E.
    Clin Chem; 2006 Sep; 52(9):1771-6. PubMed ID: 16858070
    [Abstract] [Full Text] [Related]

  • 4. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W.
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [Abstract] [Full Text] [Related]

  • 5. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 6. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH, Johnson ES, Thorp ML, Yang X.
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [Abstract] [Full Text] [Related]

  • 7. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis.
    Goodman WG.
    Semin Dial; 2007 Jul; 20(1):1-4. PubMed ID: 17244110
    [Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J, National Kidney Foundation.
    Semin Dial; 2004 Nov; 17(5):349-50. PubMed ID: 15461740
    [Abstract] [Full Text] [Related]

  • 10. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
    Wazny LD, Raymond CB, Lesperance EM, Bernstein KN.
    CANNT J; 2008 Nov; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
    [Abstract] [Full Text] [Related]

  • 11. An automated 'bio-intact' PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease.
    Savoca R, Bock A, Kraenzlin ME, Schmid HR, Huber AR.
    Clin Chim Acta; 2004 May; 343(1-2):167-71. PubMed ID: 15115690
    [Abstract] [Full Text] [Related]

  • 12. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B.
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [Abstract] [Full Text] [Related]

  • 13. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
    Lebner AC, Beard KM, Soroka SD, Cournoyer SH, Da Roza GA, Geary DF, Mendelssohn DC.
    Nephrol Dial Transplant; 2011 Jan; 26(1):156-63. PubMed ID: 20667990
    [Abstract] [Full Text] [Related]

  • 14. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Jan; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 15. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR.
    Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
    [Abstract] [Full Text] [Related]

  • 16. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M, Shahapuni I, Oprisiu R, El Esper N, Morinière P, Massy Z, Choukroun G, Fournier A.
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
    Lorenzo V, Martin-Malo A, Perez-Garcia R, Torregrosa JV, Vega N, de Francisco AL, Cases A.
    Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
    [Abstract] [Full Text] [Related]

  • 18. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
    John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4287-90. PubMed ID: 10566687
    [Abstract] [Full Text] [Related]

  • 19. Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle.
    Al Aly Z, González EA, Martin KJ, Gellens ME.
    Am J Nephrol; 2004 Nov; 24(4):422-6. PubMed ID: 15308874
    [Abstract] [Full Text] [Related]

  • 20. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
    Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC.
    Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.